SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
ImmunityBio converts from Immunomedics
An SI Board Since February 2023
Posts SubjectMarks Bans Symbol
1554 51 0 IBRX
Emcee:  TinfoilHat Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
617Does anyone know Catanzaro's rationale for a $4.75 price target? Are we allbobbseytwins200118/19/2024
616Just an FYI: weakness today probably due to: Piper Sandler analyst Joseph Cataluckydog88-8/19/2024
615Merck signed a big licensing agreement with Daiichi for their ADC pipeline. ADCTinfoilHat48/19/2024
614Merck needs Anktiva desperately. Every attempt to extend the patent on Keytruda ghettogoulash-8/19/2024
613Far be it from me to take the under, but here you go: I don't think a confeTinfoilHat58/13/2024
612Ha ha. Agree totally. Very sophomoric, at best. I too bought more today, adding galt-8/13/2024
611Ha looks like you are spending too much time on stocktwits like me! I need to stsukit38/13/2024
610The total lack of market skill is baffling - Only to be outdone by the ignoranJJINV-8/13/2024
609When we received the CRL, PSS rode in and supplied funds, but took a much greateDavidoff18/13/2024
608Yeah, doubled my position today share wise so hopefully not a mistake....erippetoe-8/13/2024
607Completely agree, and at the risk of repeating the points you made with great clFitzhughlaw58/13/2024
606Agreed. Pretty silly not to have a call and provide some level of guidance or resukit18/13/2024
605The news is fine. What is not fine is the company's "basement strategybobbseytwins200138/13/2024
604Holy shit can we get some actual good news. This stock is starting to trigger mysukit28/13/2024
603SAN DIEGO (AP) — SAN DIEGO (AP) — ImmunityBio, Inc. (IBRX) on Monday reported azagnut1-8/13/2024
602[graphic]urslor-8/12/2024
601Merck discontinues late stage trial of experimental lung cancer treatment after Redman123438/8/2024
600My 2c market wants income and that will change outlook. Lots of good stuff in thzagnut128/6/2024
599One would think that is good news... Still confused ... what does the market nJJINV-8/6/2024
598ImmunityBio Announces Study of ANKTIVA® in Combination with the AdHzagnut1-8/6/2024
597Who's coming at me? Here come the fisticuffs!! Haha, thanks for whomever stTinfoilHat48/4/2024
596Anktiva since August 1st is on the the Medicare coverage plan for Aetna. If thesRedman123428/3/2024
595Several very important things seemly have happened and are being posted about onRedman123418/3/2024
594Jesus me too. Last couple of months have been painful. Just bought more as I am sukit18/1/2024
593Starting to feel the flamejargonweary18/1/2024
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News